- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Nov 12, 2025 | 6.9M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 11.76M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 10.13M sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 37.85K sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 36.06K sh |
| Capex | Q2 2026 · Sep 30, 2025 | $712 |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | −$533.98K |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | −$2.5M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $2.39M |
| Short Term Debt | Q2 2026 · Mar 31, 2025 | $2.85M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $169.36K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $614.21K |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | −$27.72M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | −$26.8M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | −$25.35M |
| Stockholders Equity restated | Q2 2026 · Sep 30, 2024 | −$32.76M |
| Stockholders Equity restated | Q2 2026 · Jun 30, 2024 | −$31.47M |
| Stockholders Equity restated | Q2 2026 · Mar 31, 2024 | −$33.69M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $29.73M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $29.51M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $30.83M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $30.71M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $1.14M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $3.01M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $3.12M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $5.36M |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$0.07 |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$0.49 |
| Eps Diluted restated | Q2 2026 · Sep 30, 2024 | −$88.56 |
| Eps Diluted restated | Q2 2026 · Sep 30, 2024 | −$163.15 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$0.07 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$0.49 |
| Eps Basic restated | Q2 2026 · Sep 30, 2024 | −$88.56 |
| Eps Basic restated | Q2 2026 · Sep 30, 2024 | −$163.15 |
| Rd Expense | Q2 2026 · Sep 30, 2025 | $730.09K |
| Rd Expense | Q2 2026 · Sep 30, 2025 | $1.44M |
| Rd Expense | Q2 2026 · Sep 30, 2024 | $734.92K |
| Rd Expense | Q2 2026 · Sep 30, 2024 | $1.64M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$794.15K |
| Net Income | Q2 2026 · Sep 30, 2025 | −$5M |
| Net Income | Q2 2026 · Jun 30, 2025 | −$4.21M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$3.35M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$5.88M |
| Net Income | Q2 2026 · Jun 30, 2024 | −$2.53M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$1.98M |
| Operating Income | Q2 2026 · Sep 30, 2025 | −$3.74M |
| Operating Income | Q2 2026 · Sep 30, 2024 | −$1.57M |
| Operating Income | Q2 2026 · Sep 30, 2024 | −$4.95M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $1.2M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $2.51M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2024 | $1.21M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2024 | $2.73M |